Aspect Biosystems Ltd., a Canadian biotech company that specializes in developing 3D bioprinted tissues, has wrapped up its first round of institutional financing. The investment round, led by venture capital firm Pangaea Ventures, brought in funding from both existing and new investors.
from 3ders.org - http://www.3ders.org
martes, 19 de septiembre de 2017
2:35
MR: EDITOR
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Related Posts